The Genetic Technology TechVision Opportunity Engine (TOE) outlines the impact of artificial intelligence (AI) on the global drug discovery and development landscape. Berg Health’s precision medicine platforms and a clinical overview of the company’s pipeline have been profiled in the TOE. Furthermore, IP trends, research aspects, and AI-medicine strategies have also been described.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
1. Recent Advances in Artificial Intelligence in Pharma
- Artificial Intelligence - Overall Impact and Opportunity Leverage
- AI-based Precision Medicine
- AI-based Precision Medicine Innovation Scouting
- AI-driven Medicine: Approaches, Features, and Targeted Areas
2. Clinical Trial Analysis and Key Contacts
- Clinical Trial Analysis: Bergh Health’s Pipeline
- Key Contacts
